Use of Intravenous Immunoglobulin in Multiple Sclerosis

ISSN： 1173-8804

Source： BioDrugs, Vol.9, Iss.6, 1998-06, pp. : 465-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Immunoglobulin Use in Patients with Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

By Mittmann Nicole

American Journal of Clinical Dermatology, Vol. 7, Iss. 6, 2006-01 ,pp. : 359-368

Adis International

Access to resources Recommend Favorite

Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use

By Chérin Patrick

BioDrugs, Vol. 24, Iss. 4, 2010-08 ,pp. : 211-223

Adis International

Access to resources Recommend Favorite

The Optimum Use of Intravenous Immunoglobulin for Prophylaxis of Opportunistic Infection in HIV-Infected Adults

By Kiehl M.G. Müller C.

BioDrugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 265-273

Adis International

Access to resources Recommend Favorite

Cladribine: A Review of its Use in Multiple Sclerosis

By Langtry H.D. Lamb H.M.

BioDrugs, Vol. 9, Iss. 5, 1998-05 ,pp. : 419-433

Adis International

Access to resources Recommend Favorite

Appropriate Use of Interferon Beta-1a in Multiple Sclerosis

By Jacobs L. Brownscheidle C.M.

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite